Cargando…
The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175619/ https://www.ncbi.nlm.nih.gov/pubmed/25189712 http://dx.doi.org/10.1186/1476-511X-13-145 |
_version_ | 1782336510773690368 |
---|---|
author | Zou, Jin-Guo Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Pan, Shuo Adi, Dilare Liu, Fen Chen, Bang-Dang |
author_facet | Zou, Jin-Guo Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Pan, Shuo Adi, Dilare Liu, Fen Chen, Bang-Dang |
author_sort | Zou, Jin-Guo |
collection | PubMed |
description | BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth response in vascular smooth muscle cells (VSMCs) as well as the anti-platelet effect. EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. This study assessed the association between human CYP1A1 gene polymorphisms and coronary artery disease (CAD) in the Uygur and Han in China. METHODS: Two independent case–control studies that recruited Han (389 patients with CAD and 411 controls) and Uygur participants (293 patients with CAD and 408 controls) analyzed the relationship between CYP1A1 single nucleotide polymorphisms (SNPs: rs4886605, rs12441817, rs4646422 and rs1048943) and CAD. All patients with CAD and controls were genotyped for the four SNPs of CYP1A1 using TaqMan SNP genotyping assays. RESULTS: In the Uygur group, the distribution of the dominant model(CC vs CT + TT) of rs4886605 for the total sample and the males was significantly different between CAD patients and control participants (P = 0.001 and P = 0.012, respectively), The difference remained significant after a multivariate adjustment (P = 0.018, P = 0.015, respectively). The rs12441817 was also associated with CAD in a dominant model for all participants (P = 0.003) and men (P = 0.012), and the difference remained significant after a multivariate adjustment (P = 0.016, P = 0.002, respectively). However, we did not observe differences in the Uygur females and Han group with regard to the allele frequency or genotypic distribution of rs4886605 and rs12441817 between patients with CAD and control participants. Patients with CAD did not significantly differ from the control participants with regard to the distributions of rs4646422 and rs1048943 genotypes, the dominant model, the recessive model, or allele frequency in the Han and Uygur groups. CONCLUSION: Both rs4886605 and rs12441817 SNPs of the CYP1A1 gene are associated with CAD in the Uygur population of China. |
format | Online Article Text |
id | pubmed-4175619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41756192014-09-27 The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China Zou, Jin-Guo Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Pan, Shuo Adi, Dilare Liu, Fen Chen, Bang-Dang Lipids Health Dis Research BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth response in vascular smooth muscle cells (VSMCs) as well as the anti-platelet effect. EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. This study assessed the association between human CYP1A1 gene polymorphisms and coronary artery disease (CAD) in the Uygur and Han in China. METHODS: Two independent case–control studies that recruited Han (389 patients with CAD and 411 controls) and Uygur participants (293 patients with CAD and 408 controls) analyzed the relationship between CYP1A1 single nucleotide polymorphisms (SNPs: rs4886605, rs12441817, rs4646422 and rs1048943) and CAD. All patients with CAD and controls were genotyped for the four SNPs of CYP1A1 using TaqMan SNP genotyping assays. RESULTS: In the Uygur group, the distribution of the dominant model(CC vs CT + TT) of rs4886605 for the total sample and the males was significantly different between CAD patients and control participants (P = 0.001 and P = 0.012, respectively), The difference remained significant after a multivariate adjustment (P = 0.018, P = 0.015, respectively). The rs12441817 was also associated with CAD in a dominant model for all participants (P = 0.003) and men (P = 0.012), and the difference remained significant after a multivariate adjustment (P = 0.016, P = 0.002, respectively). However, we did not observe differences in the Uygur females and Han group with regard to the allele frequency or genotypic distribution of rs4886605 and rs12441817 between patients with CAD and control participants. Patients with CAD did not significantly differ from the control participants with regard to the distributions of rs4646422 and rs1048943 genotypes, the dominant model, the recessive model, or allele frequency in the Han and Uygur groups. CONCLUSION: Both rs4886605 and rs12441817 SNPs of the CYP1A1 gene are associated with CAD in the Uygur population of China. BioMed Central 2014-09-05 /pmc/articles/PMC4175619/ /pubmed/25189712 http://dx.doi.org/10.1186/1476-511X-13-145 Text en © Zou et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zou, Jin-Guo Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Pan, Shuo Adi, Dilare Liu, Fen Chen, Bang-Dang The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title_full | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title_fullStr | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title_full_unstemmed | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title_short | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
title_sort | association between cyp1a1 genetic polymorphisms and coronary artery disease in the uygur and han of china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175619/ https://www.ncbi.nlm.nih.gov/pubmed/25189712 http://dx.doi.org/10.1186/1476-511X-13-145 |
work_keys_str_mv | AT zoujinguo theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT mayitong theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT xiexiang theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT yangyining theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT panshuo theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT adidilare theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT liufen theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT chenbangdang theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT zoujinguo associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT mayitong associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT xiexiang associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT yangyining associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT panshuo associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT adidilare associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT liufen associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina AT chenbangdang associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina |